Reset filters
  • 24 July 2007

IAS: Integrase inhibitor raltegravir (MK-0518) potent, durable and more tolerable than efavirenz in treatment-naive at 48 weeks

Read the article
  • 24 July 2007

IAS: Regular viral load testing essential for patients in resource limited settings on NNRTIs, says US resistance expert

Read the article
  • 24 July 2007

IAS: Hepatitis C clusters reveal international transmission among HIV-positive gay men

Read the article
  • 24 July 2007

IAS: Novel once-daily CCR5 antagonist, INC9471, appears potent, well tolerated after 14 days monotherapy

Read the article
  • 24 July 2007

IAS: Aciclovir treatment doesn't significantly reduce HIV or HSV-2 shedding in genital secretions

Read the article
  • 24 July 2007

IAS: Vicriviroc still effective at 48 weeks in treatment-experienced, but relationship with cancer remains uncertain

Read the article
  • 23 July 2007

IAS: Studies present reassuring data on the use of ART in patients on TB treatment

Read the article
  • 23 July 2007

IAS: Botswanan study finds low concentrations of TB drugs common in HIV-positives, predict TB treatment failure

Read the article
  • 23 July 2007

IAS: Skin cancers more common among HIV-positive people, screening recommended

Read the article

Receive the latest HIV research and conference news

Complete this form to receive regular email bulletins including the latest HIV research and conference news from aidsmap and/or updates from Terrence Higgins Trust.

Get regular email bulletins

Please let us know how you'd like to be contacted by ticking the options below.